The increased level of tumor necrosis factor-α (TNF-α) in the circulation of patients with chronic heart failure since Levine (22) first advocated it in 1990, has been widely explored for decades, and accumulating studies have elucidated the pivotal role of the inflammatory biomarkers in acute and chronic heart failure (7, 19–21). The gene discussed is TNF; the disease is congestive heart failure.